Predictive factors in radiotherapy for non-small cell lung cancer: present status
- 1 January 2001
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 31 (1), 43-56
- https://doi.org/10.1016/s0169-5002(00)00156-2
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999
- 243 Spanish lung cancer group randomized trial of preoperative chemotherapy (cisplatin either 50 mg/m2 or 100 mg/m2) in stage IIIA (N2) non-small cell lung cancer (NSCLC)Lung Cancer, 1997
- Revisions in the International System for Staging Lung CancerChest, 1997
- Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.Journal of Clinical Oncology, 1995
- Results of cancer and leukemia group B protocol 8935The Journal of Thoracic and Cardiovascular Surgery, 1995
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramideJournal of Chronic Diseases, 1960
- Preliminary Studies on the Natural History of Lung CancerRadiology, 1957